Literature DB >> 16263092

Inhibition of sphingolipid synthesis impairs cellular activation, cytokine production and proliferation in human lymphocytes.

Norbert Blank1, Martin Schiller, Christoph Gabler, Joachim R Kalden, Hanns-Martin Lorenz.   

Abstract

The localisation of the T cell receptor and other signalling molecules in membrane microdomains (MM) is essential for the activation of T lymphocytes. These MM are stabilized by sphingolipids and cholesterol. It was recently shown that the activation of T lymphocytes leads to the confluence of small MM and the formation of an immunological synapse which is thought to be essential for a persistent activation and proliferation. We studied the effects of an inhibition of sphingolipid synthesis on T lymphocyte function. Both sphingolipid inhibitors, PDMP and myriocin, inhibited glucosphingolipids in whole cell lipid extracts and in MM. Both compounds inhibited the proliferation of superantigen-stimulated PBMC without inducing cell death. However, only the ceramide-like compound PDMP inhibited the expression of activation markers and the secretion of IFN-gamma which was not seen with myriocin treatment. The MM localisation of Lck and LAT was not significantly reduced in PDMP-treated cells. In conclusion, our results show that glucosphingolipids are necessary for cell growth of human T lymphocytes. However, inhibition of glucosphingolipid synthesis itself did not inhibit cellular activation. Our data show that glucosphingolipids - in contrast to cholesterol - are not essential for the stabilisation of MM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16263092     DOI: 10.1016/j.bcp.2005.10.004

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

1.  CD4 and CD8 T cells require different membrane gangliosides for activation.

Authors:  Masakazu Nagafuku; Kaori Okuyama; Yuri Onimaru; Akemi Suzuki; Yuta Odagiri; Tadashi Yamashita; Katsunori Iwasaki; Michihiro Fujiwara; Motoaki Takayanagi; Isao Ohno; Jin-ichi Inokuchi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

Review 2.  Heterogeneity of gangliosides among T cell subsets.

Authors:  Jin-ichi Inokuchi; Masakazu Nagafuku; Isao Ohno; Akemi Suzuki
Journal:  Cell Mol Life Sci       Date:  2012-12-12       Impact factor: 9.261

3.  Lowering glycosphingolipid levels in CD4+ T cells attenuates T cell receptor signaling, cytokine production, and differentiation to the Th17 lineage.

Authors:  Yunxiang Zhu; Nathan Gumlaw; Jozsef Karman; Hongmei Zhao; Jinhua Zhang; Ji-Lei Jiang; Pete Maniatis; Andrea Edling; Wei-Lien Chuang; Craig Siegel; James A Shayman; Johanne Kaplan; Canwen Jiang; Seng H Cheng
Journal:  J Biol Chem       Date:  2011-03-14       Impact factor: 5.157

Review 4.  Gangliosides in T cell development and function of mice.

Authors:  Jin-Ichi Inokuchi; Masakazu Nagafuku
Journal:  Glycoconj J       Date:  2022-02-14       Impact factor: 2.916

5.  LXR directly regulates glycosphingolipid synthesis and affects human CD4+ T cell function.

Authors:  Kirsty E Waddington; George A Robinson; Beatriz Rubio-Cuesta; Eden Chrifi-Alaoui; Sara Andreone; Kok-Siong Poon; Iveta Ivanova; Lucia Martin-Gutierrez; Dylan M Owen; Elizabeth C Jury; Inés Pineda-Torra
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-25       Impact factor: 11.205

6.  Interference with distinct steps of sphingolipid synthesis and signaling attenuates proliferation of U87MG glioma cells.

Authors:  Eva Bernhart; Sabine Damm; Andrea Wintersperger; Christoph Nusshold; Anna Martina Brunner; Ioanna Plastira; Gerald Rechberger; Helga Reicher; Christian Wadsack; Andreas Zimmer; Ernst Malle; Wolfgang Sattler
Journal:  Biochem Pharmacol       Date:  2015-05-19       Impact factor: 5.858

7.  Age-dependent changes in the sphingolipid composition of mouse CD4+ T cell membranes and immune synapses implicate glucosylceramides in age-related T cell dysfunction.

Authors:  Alberto Molano; Zhaofeng Huang; Melissa G Marko; Angelo Azzi; Dayong Wu; Elaine Wang; Samuel L Kelly; Alfred H Merrill; Stephen C Bunnell; Simin Nikbin Meydani
Journal:  PLoS One       Date:  2012-10-26       Impact factor: 3.240

8.  Reducing FLI1 levels in the MRL/lpr lupus mouse model impacts T cell function by modulating glycosphingolipid metabolism.

Authors:  Erin Morris Richard; Thirumagal Thiyagarajan; Marlene A Bunni; Fahmin Basher; Patrick O Roddy; Leah J Siskind; Paul J Nietert; Tamara K Nowling
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.